Trump administration to reclassify marijuana as Schedule III, easing research barriers but not legalizing the drug or ...

The Trump administration moved marijuana into a category of drugs considered less dangerous, on par with Tylenol with codeine ...

The move, which could open up medical research on cannabis as well as banking services for growers, follows an executive ...

Tilray Medical Poised to Accelerate U.S. Medical Cannabis Access for PatientsNEW YORK, April 23, 2026 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (“Tilray”, “our”, “we” or the “Company”) (NASDAQ: TLRY; ...

The Trump administration is reclassifying marijuana as a less dangerous drug, a significant policy shift that could make it ...

VA lawmakers reject gov’s marijuana amendments; CA dispensary drive-thrus; Federal cannabis research bill; Legalization poll ...

Canadian cannabis companies surged Wednesday after an Axios report said that the Trump Administration could move to reclassify marijuana.

The AdvisorShares Pure US Cannabis ETF (MSOS) soared on news that the federal government may soon reschedule cannabis. It has ...

The White House psychedelics executive order accelerates research, clinical trials and "Right to Try" access for drugs like ...

President Donald Trump's acting attorney general on Thursday signed an order reclassifying state-licensed medical marijuana ...

Nearly five years after the Alabama Legislature approved a medical cannabis program in the state, the weeks-long process of ...